We are live on
!
Find out more
Insmed
INSM
INSM
114 hedge funds and large institutions have $970M invested in Insmed in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
14% more funds holding
Funds holding: 100 → 114 (+14)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.86% less ownership
Funds ownership: 91.9% → 91.04% (-0.86%)
3% less capital invested
Capital invested by funds: $998M → $970M (-$28.3M)
71% less call options, than puts
Call options by funds: $6.39M | Put options by funds: $21.8M
Holders
114
Holders Change
+14
Holders Change %
+14%
% of All Funds
2.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
43
Reduced
30
Closed
9
Calls
$6.39M
Puts
$21.8M
Net Calls
-$15.5M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$28.2M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$9.2M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$8.11M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.6M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.1M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.77M |
| 2 |
JP Morgan Chase
New York
|
-$8.04M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$7.9M |
| 4 |
O
OrbiMed
New York
|
-$7.13M |
| 5 |
Morgan Stanley
New York
|
-$2.32M |
